Kalpesh Shah Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 Highway 33, Neptune City, NJ 07753 Phone: 732-455-8102 |
Dr. Andrew N Hanna Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1905 State Route 33, Neptune City, NJ 07753 Phone: 732-988-2100 |
Rebecca Sun Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1905 State Route 33, Neptune City, NJ 07753 Phone: 732-988-2100 |
News Archive
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.
The dominant model of disease today is, as 30 years ago, still biomedical, with molecular biology being the basic scientific discipline.
Scientists from the University of Cambridge have identified 27 genes that are associated with either Asperger Syndrome (AS) and/or autistic traits and/or empathy. The research will be published tomorrow in the journal Autism Research. This is the first candidate gene study of its kind.
As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.
"Despite the apparent burst of White House attention to Africa from the First Lady's tourism-heavy visit to South Africa and Botswana last week, there are still plenty of reasons that many (including me) remain disappointed by the administration's efforts so far," Todd Moss, vice president for corporate affairs and senior fellow at the Center for Global Development, writes on the "Rethinking U.S. Foreign Assistance Blog."
› Verified 4 days ago